Author Correction: PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein
Autor: | Kam M. Hui, Wei Peng Yong, Chin Hin Ng, Lingzhi Wang, Iain Beehuat Tan, Jianbiao Zhou, Qi Zeng, John Shyi Peng Yuen, Yeoh Khay Guan, Su Pin Choo, Soo-Chin Lee, Boon Cher Goh, Matthew C.H. Ng, Cheng Ean Chee, Nicholas Yan Zhi Tan, Joanne Ngeow, Joel Sng, Min Thura, Wee Joo Chng, Clarinda Chua, Sim Mei Yi, Eugene Shen Ann Yeo, Jie Li, Jean Paul Thiery, Edmund Chiong, Abdul Qader Omer Al-aidaroos, Henry Sun Sien Ho, Jimmy Bok Yan So, Abhishek Gupta |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2021 |
Předmět: |
Multidisciplinary
biology business.industry medicine.medical_treatment Science General Physics and Astronomy General Chemistry Immunotherapy General Biochemistry Genetics and Molecular Biology Cancer immunotherapy Drug development medicine biology.protein Cancer research Antibody business Tumor immunology |
Zdroj: | Nature Communications, Vol 12, Iss 1, Pp 1-1 (2021) |
ISSN: | 2041-1723 |
Databáze: | OpenAIRE |
Externí odkaz: |